We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Predicts In-Hospital Cardiac Arrest Minutes in Advance

By HospiMedica International staff writers
Posted on 03 May 2026

Sudden cardiac arrest, the abrupt loss of heart function, often arises without clear warning in hospitalized patients. More...

Clinicians must sift through faint signals from routine monitoring while limiting alarm fatigue that strains limited staff. Earlier, reliable prediction could enable timely intervention and better resource allocation. To help address this challenge, researchers have developed an artificial intelligence model that forecasts impending cardiac events minutes before they occur.

Called the Cardiac Autoregressive Model for ECG Language-Modeling (CAMEL), the system was created by clinicians at Penn Medicine (Philadelphia, PA, USA) working with computer scientists at the University of Pennsylvania’s School of Engineering and Applied Science. It treats electrocardiographic (ECG) data as a time-evolving signal whose patterns can be learned rather than as static snapshots. The work is published as a 2026 preprint on arXiv.

CAMEL converts segments of ECG waveforms into a representation that can be interpreted alongside clinical text, including physician notes and laboratory results. By integrating signal and text, the model reasons about how subtle rhythm variations may foreshadow deterioration. Unlike tools limited to 10‑second strips, it is designed to analyze hours of hospital telemetry, expanding the detection window to enable warnings within 10 to 15 minutes before an event.

According to the investigators, the model has shown promising results when analyzing normal sinus rhythm to surface early indicators of high risk for in‑hospital cardiac arrest. The approach targets dangerous arrhythmias such as ventricular fibrillation and ventricular tachycardia. The aim is to identify risk before overt abnormalities appear on standard monitors.

The team plans background testing that processes real‑time patient data without alerting staff, then compares predictions with outcomes to assess performance against current care and minimize alarm burden. They also see potential applications beyond the hospital through consumer wearable devices. These steps are intended to determine whether proactive forecasts can be delivered safely and reliably at the bedside.

“The last thing I want to do is alert nurses and technicians on the floor at 2 a.m. to intervene based on a false signal. Every time we trigger an alarm, we are diverting a finite resource from another patient who may be in need. In a clinical setting, we have to be certain,” said Rajat Deo, cardiologist at the Perelman School of Medicine.

Related Links
Penn Medicine
University of Pennsylvania’s School of Engineering and Applied Science


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.